For a deeper understanding of tea tree oil: Fresh is best - why we should only use fresh oil at any concentration

International Journal of Aromatherapy

Volumn 16, Issue 3-4, 2006, Pages 109-115

  Wabner, D ^a   Geier, K ^a   Hauck, D ^a  

^a Natural Oils Research Association NORA International   (Germany)

Author keywords

Adverse reactions; Avoidance and destruction of peroxides; Daily opening; Peroxide value; Tea tree oil

Indexed keywords

COSMETIC; ESSENTIAL OIL; PEROXIDE; TEA TREE OIL; TERPENE;

ARTICLE; DESTRUCTION; DILUTION; DRUG ABSORPTION; DRUG DECOMPOSITION; DRUG STABILITY; DRUG STORAGE; EUROPEAN UNION; HEALTH SURVEY; HUMAN; IN VIVO STUDY; MEDICAL LITERATURE; OXIDATION; QUESTIONNAIRE; SENSITIZATION; SKIN ABSORPTION; SKIN DISEASE; SKIN IRRITATION; SKIN TOXICITY;

EID: 33751440683     PISSN: 09624562     EISSN: 14769409     Source Type: Journal    
DOI: 10.1016/j.ijat.2006.09.009     Document Type: Article

References (36)

1. Aspres N., and Freeman S. Predictive testing for irritancy and allergenicity of tea tree oil in normal human subjects. Exog Dermatol (2003) 258-261
2. ATTIA (Australian Tea Tree Industry Association). Sydney, Personal communication; 2006.
3. BfR - Bundesinstitut für Risikobewertung, Verwendung von unverdünntem Teebaumöl als kosmetisches Mittel, Stellungnahme des BfR vom 01.09.2003, Berlin.
4. Brophy J.I., et al. Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree oil). J Agric Fd Chem 37 (1989) 1330-1335
5. Burfield T. Questionnaire adverse reactions with tea tree oil. Cropwatch, London; 2005.
6. Carson C.F., and Riley T.V. Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact Dermatitis 45 (2001) 65-67
7. Carson C.F., Hammer K.A., and Riley T.V. Compilation and review of published and unpublished tea tree oil literature. 3 (2003), RIRDC Publication p. 1-48
8. Carson C.F., Ashton L., Dry L., Smith D.W., and Riley T.V. Antiviral activity of tea tree oil, in vitro and in vivo. 5/130 (2005), RIRDC Publication p. 1-45
9. COLIPA (European Cosmetic, Toiletry and Perfumery Association) Recommendation No 12.20002. Use of tea-tree-oil in cosmetic products, Paris; 2002.
10. Finlay-Jones J., Riley T., and Carson C. Anti-inflammatory activity of tea tree oil. 1/10 (2001), RIRDC Publication p. 1-26
11. Fletcher J.P., Cassella J.P., Hughes D., and Cassella S. An evaluation of the mutagenic, potential of commercially available tea tree oil in the United Kingdom. Int J Aromatherapy 15 (2005) 81-86
12. Geier K. Qualitäts-Sicherung von etherischen Ölen. Doktor-Arbeit Technische Universität München; 2006.
13. Hammer KA, Dry L, Johnson M, Michalek E, Carson, CF, Riley TV. Antimicrobial activity of tea tree oil against oral microorganisms. RIRDC Publication 2003;63/019.
14. Harkenthal M., Reichling J., Geiss H.K., and Saller R. Australisches teebaumöl, oxidationsprodukte als mögliche ursache von kontaktdermatiden. Pharmazie 143 (1998) 26-30
15. Harkenthal M., Hausen B.M., and Reichling J. 1,2,4-Trihydroxy menthane, a contact allergen from oxidized Australian tea tree oil. Pharmazie 55 (2000) 153-154
16. Hauck D. Oxidation und alterung etherischer öle. Doktor-Arbeit, Uni Witten-Herdecke und Technische Universität München; 2006 in Arbeit.
17. Hausen, BM, Kontaktallergie auf Teebaumöl und Ascaridol, Akt Dermatol 24, Georg Thieme Verlag Stuttgart; 1998:60-2.
18. Hausen B.M. Evaluation of the main contact allergens in oxidized tea tree oil. Letter to the editor. Dermatitis 15 (2004) 213-214
19. Hausen B.M., Reichling J., and Harkenthal M. Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am J Contact Dermatitis 10 (1999) 68-77
20. Howie J. Tea tree oil - use it wisely. InEssence 4 (2005) 16-18
21. Knight T.E., and Hausen B.M. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol 30 (1994) 423-427
22. Koh K.J., Pearce A.L., Marshman G., Finlay-Jones J.J., and Hart P.H. Therapeutica. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 147 (2002) 1212-1217
23. N.N.1, Personal communication; 2006.
24. N.N.2, Personal communication; 2006.
25. Pirker C., Hausen B.M., Uter W., Hillen U., Brasch J., Bayerl C., et al. Sensitization to tea tree oil in Germany and Austria. A multicenter study of the German contact dermatitis group. J Deutschen Dermatolog Gesellschaft (JDDG) 8 (2003) 629-634
26. Reichling J., Harkenthal M., and Saller R. Australisches Teebaumöl (Melaleuca aetheroleum), Pharmazeutische Qualität, Wirksamkeit und Toxizität. Schweiz Zschr Ganzheits Medizin 13 (2001) 30-39
27. Reichling J., Iten F., and Saller R. Australisches Teebaumöl (Melaleuca aetheroleum), Pharmazeutische Qualität, Wrksamkeit und Toxizität. Phytotherapie 3 (2003) 32-39
28. Riedl R. (unpublished part of SCCP submission) Summary report and discussion of adverse skin reactions potentially resulting from topical tea tree oil use received from five companies marketing tea tree products, Sydney; 2006.
29. SCCP (Scientific Committee on Consumer Products)-Opinion 0843/04 on tea tree oil. Brüssel; 2004.
30. Southwell I.A., Freeman S., and Rubel D. Skin irritancy of tea tree oil. J Essent Oil Res 9 (1997) 47-52
31. Storm R. Sensient essential oils. Bremen, Personal communication; 2006.
32. Wabner D. The peroxide value - a new tool for the quality control of essential oils. Int J Aromatherapy 12 (2002) 142-144
33. Wabner D, Geier K. The peroxide value, methods and use. Int J Aromatherapy, in preparation.
34. Wabner D., Hammer-Klafke A., and Zimmermann E. Portraits der wichtigsten etherischen Öle, Schriftenreihe etherische Öle für Therapie. Kosmetik und Parfümerie 8 (2006) 79-80
35. Wabner D, Geier K, Hauck D. Bleibt uns das Teebaum-Öl erhalten? Zur Regulierungs-Wut der Europäischen Union, Natural Oils Research Association, NORA-International, 2006:1-7.
36. Woeber K., and Krombach M. Zur Frage der Sensibilisierung durch ätherische Öle. Berufsdermatosen 17 (1969) 320-326